Michael Patterson is the CEO of US Cannabis Pharmaceutical Research and Development LLC (US Cannabis), a privately-held developmental consulting firm which was established in 2014 with the mission of moving society forward through legalized cannabis. US Cannabis develops the legal cannabis/hemp/cbd markets globally across all platforms (education, cultivation, production, dispensing, research and development, management operations and compliance, and physician services). US Cannabis currently works with national, state, and local governments, sovereign nations, and public/private companies in all aspects of the cannabis/hemp/CBD industry throughout the United States and Internationally.
Mr. Patterson is an internationally recognized speaker, subject matter expert in the global cannabis/hemp/cbd industry, and published author. Michael is a member of the Scientific Advisory Board for Akers Bioscience, a NASDAQ listed biotechnology company, Editorial Board Member for AJEM-American Journal of Endocannabinoid Medicine (the world’s first peer-reviewed printed scientific journal dedicated to the study of endocannabinoid science and medicine). Mr. Patterson is also a board member for the Medical Cannabis Society, Tourette’s Syndrome Awareness Foundation, cannabis/cbd industry writer for Florida MD Magazine, Orlando Medical News, and licensed Occupational Therapist and Nursing Home Administrator in 4 states.